Ipsen, a global specialty care-driven biopharmaceutical company, has appointed Laura Réveillon, PhD as EVP, Strategy & ...

Aptar CSP Technologies, part of AptarGroup Inc., has expanded its service offerings with the launch of a cGMP-compliant ...

PCI Pharma Services has acquired Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO and subsidiary of Japan-based ...

Following the acquisition of IFF Pharma Solutions, Roquette has created 2 complementary Business Groups: Health & Pharma ...

Matica Biotechnology, a specialized CDMO for cell and gene therapies, has partnered with the National Center for Therapeutics ...

Formulation challenges can feel like roadblocks — from API incompatibility and dissolution delays to safety concerns and ...

VERAXA Biotech AG ( VERAXA) has entered a co-discovery alliance with OmniAb, Inc. for the development of a novel bispecific antibody drug conjugate (bsADC) program targeting solid tumors.

Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common stock, plus one non-tradeable contingent ...

SK pharmteco has opened its new Current Good Manufacturing Practice (CGMP) plasmid suite at its facility in King of Prussia, ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s IMAAVY (nipocalimab-aahu), a human FcRn-blocking ...

Merck has initiated construction of a $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware.

Satsuma Pharmaceuticals, Inc. and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd, announced that the U.S.